Meso Numismatics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 09, 2022 at 06:07 am EST
Share
Meso Numismatics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 0.374359 million compared to USD 0.165042 million a year ago. Net loss was USD 1.34 million compared to USD 9.92 million a year ago. Basic loss per share from continuing operations was USD 0.11 compared to USD 0.82 a year ago.
For the nine months, sales was USD 0.988958 million compared to USD 0.185254 million a year ago. Net loss was USD 4.51 million compared to USD 11.31 million a year ago. Basic loss per share from continuing operations was USD 0.37 compared to USD 1 a year ago.
Meso Numismatics, Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary, Global Stem Cell Group Inc. It distributes stem cells and other regenerative based cell lines and equipment internationally and specializes in education and training physicians in regenerative medicine. It works with doctors and staff to provide products, solutions, equipment, services, and training to help them in the application of stem cell therapies. It is focused on the manufacturing and commercialization of viable cell therapy and immune support-related products. Its professional trademarked association, The International Society for Stem Cell Application (ISCCA), is a global network of medical professionals. Its flagship operation in Istanbul employs targeted combinations of exosomes, allogeneic human mesenchymal cells, and autologous bone marrow and adipose-derived stem cells to treat an array of diseases and debilitating medical conditions.
MESO NUMISMATICS, INC. 